Dr Pepper Snapple Group Reaches New 52-Week High (DPS)

NEW YORK ( TheStreet) -- Dr Pepper Snapple Group (NYSE: DPS) hit a new 52-week high Friday as it is currently trading at $44.15, above its previous 52-week high of $44 with 137,121 shares traded as of 10:10 a.m. ET. Average volume has been 2.1 million shares over the past 30 days.

Dr Pepper Snapple Group has a market cap of $9.24 billion and is part of the consumer goods sector and food & beverage industry. Shares are up 10.5% year to date as of the close of trading on Thursday.

Dr Pepper Snapple Group, Inc. engages in the ownership, manufacture, and distribution of non-alcoholic beverages in the United States, Canada, Mexico, and the Caribbean. The company has a P/E ratio of 16.2, above the average food & beverage industry P/E ratio of 16 and below the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates Dr Pepper Snapple Group as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, notable return on equity, reasonable valuation levels, solid stock price performance and expanding profit margins. We feel these strengths outweigh the fact that the company has had sub par growth in net income. You can view the full Dr Pepper Snapple Group Ratings Report.

See all 52-week high stocks or get investment ideas from our investment research center.
null

If you liked this article you might like

Coca-Cola CEO: Here's How We Are Thinking About Acquisitions

Coca-Cola CEO: Here's How We Are Thinking About Acquisitions

Coca-Cola CEO Talks Beverage Giant's Appetite to Do Big Deals

Coca-Cola CEO Talks Beverage Giant's Appetite to Do Big Deals

Coca-Cola Posts 20% Decline in Net Revenue, Yet Saw Organic Sales Grow by 6%

Coca-Cola Posts 20% Decline in Net Revenue, Yet Saw Organic Sales Grow by 6%

Inflation, Chipotle, Credit Suisse and Sam's Club - 5 Things You Must Know

Inflation, Chipotle, Credit Suisse and Sam's Club - 5 Things You Must Know

Will Inflation Set Stocks' Hearts Aflutter or Be a Poison Arrow? -- Market Recon

Will Inflation Set Stocks' Hearts Aflutter or Be a Poison Arrow? -- Market Recon